Navigation Links
Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy

BOSTON, June 11 /PRNewswire/ -- Allied Minds has established SoundCure, Inc. to improve the lives of people suffering from tinnitus (ringing in the ear). Allied Minds, a seed investment corporation specializing in early stage university business ventures, will provide the initial funding and has partnered with the University of California at Irvine to establish SoundCure, LLC to commercialize a novel acoustic therapy for the treatment and suppression of tinnitus originally developed at UC Irvine.

Tinnitus is a debilitating disease characterized by a ringing in the ear in the absence of any external sound. It is believed that over 17% of the general population suffers from tinnitus and based on a recent report from the Department of Veterans Affairs, tinnitus is now the #1 disability affecting returning troops. While tinnitus can affect anyone, it is more common with increasing age and occurs at higher rates with individuals who work in noisy environments or listen to loud music for prolonged periods of time.

SoundCure is actively developing technology that was first pioneered at the University of California at Irvine by Dr. Fan-Gang Zeng and Dr. Qing Tang as a treatment to quiet the ringing in their patient's ears. Of the many available treatments for tinnitus few can provide any relief beyond simple masking (providing a sound louder than the tinnitus) while others require the use of long retraining regimes or the use of powerful drugs with similarly dangerous side effects. The SoundCure technology does not require sounds louder than the tinnitus being treated and uses customized sound frequencies and pulsed tones to counter the effects of tinnitus. The technology has shown to provide long-term suppression of tinnitus through treatment.

"We are very excited about the contribution that SoundCure will make to stem the terribly debilitating affects tinnitus has on its patients. SoundCure will also pioneer a transformational way technology can be applied to treat disease and provide patient care only dreamt of in the past," said Allied Minds COO, Marc Eichenberger. To learn more about SoundCure please visit

About Allied Minds, Inc.

Allied Minds is a seed investment company creating partnerships with select universities to fund corporate spin-offs resulting from successful early stage technology research. By providing corporate development support as well as funding, Allied Minds aims to guide early stage companies to commercial success, thereby generating value for all stakeholders. For more information, logon to

About the UC Irvine, Office of Technology Alliances

The UCI Office of Technology Alliances (OTA) exists to foster faculty/industry alliances and commercialization of UC Irvine technology for the broad public benefit. OTA emphasizes accessibility, timeliness, and flexibility in its operations and negotiations to ensure that the federal, state and private investment in UCI research has the greatest possible positive impact on people and the economy.

SOURCE Allied Minds, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO
2. Allied Minds Launches Novel Disinfectant/Disinfestant Technology Start-up With UC Davis
3. Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities.
4. Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents
5. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
6. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
7. Glycominds Appoints Board of Directors Chairman
8. Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests
9. Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss
10. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
11. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
Post Your Comments:
(Date:11/24/2015)... 2015 Capricor Therapeutics, Inc. (NASDAQ: ... discovery, development and commercialization of first-in-class therapeutics, today announced ... is scheduled to present at the 2015 Piper Jaffray ... EST, at The Lotte New York Palace Hotel in ... . --> . ...
(Date:11/24/2015)... Nov. 24, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: ... the company,s president and chief executive officer, will present at ... week in New York City . The ... December 1, 2015 at 9:30 a.m. EST. ... the website at least 15 minutes prior to the presentation ...
(Date:11/24/2015)... ... November 24, 2015 , ... Whitehouse Laboratories is pleased to announce that ... facility will be strictly dedicated to basic USP 61, USP 62 and USP 51 ... to have complete chemistry and micro testing performed by one supplier. Management ...
(Date:11/23/2015)... with a certain type of lung nodule visible on lung ... cancer than men with similar nodules, according to a new ... the Radiological Society of North America ... Lung nodules are small masses of tissue in the lungs ... appearance on CT. Solid nodules are dense, and they obscure ...
Breaking Biology Technology:
(Date:11/19/2015)... YORK , Nov. 19, 2015  Although some ... market is dominated by a few companies, according to ... companies own 51% of the market share of the ... The World Market for Molecular Diagnostic s ... "The market is still controlled by one company ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
Breaking Biology News(10 mins):